Clinical Trial Update: METHOD (Minimally Invasive, Endoscopically-delivered, Tolerable by Human Individuals, Non-morbid Obesity Device) Study [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a minimally invasive, endoscopically-delivered obesity device (METHOD) by Sensate LLC has completed. The study targeted non-morbid ob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• METHOD device

Snippet

Sponsor: Sensate LLC | Conditions: Obesity, Non-morbid | Phase 1 | Status: COMPLETED